Kevin J. Scanlon, Ph.D.
Founder and CEO

[Arrow] We are at the threshold of a medical revolution for the diagnosis and treatment of human disease. Our Mission at International BioScience is to integrate the Creative Knowledge of Science with the Core Disciplines of Business Development Strategies

[Arrow] Dr. Kevin J. Scanlon has relocated to Boston. His career has included: academic medicine, senior management in the pharmaceutical industry, CEO of four start-up companies and chairman of angel investment group. Some examples of his experiences includes the following:

  • Video on Non-Government Funding (Pharmaceutical Industry and Investors) for Medical Research that Dr. Scanlon did for Harvard University on funding medical research.
  • Currently, Dr. Scanlon is Professor of Practice at the D'Amore-McKim School of Business, Northeastern University. — (Teaching)
  • Dr. Kevin Scanlon has been in the investment community for 10 years. He was Chairman of Pasadena Angels Investment Group. This organization has supported entrepreneurs with seed round investments that have novel technology. (Investment Community) Read his Entrepreneurial Economy article from the Technolink Association Newsletter in Adobe PDF Format.
  • Dr. Kevin Scanlon has been CEO of four biotechnology companies. Melanoma Diagnostics has an six gene assay that can discriminated moles from melanoma. This company was sold to Myriad Genetics, Inc. (Salt Lake City, UT).
  • Dr. Scanlon has worked with entrepreneurs, the investment community and international governments in Ireland, New Zealand and China to create an innovative companies. (Events)
  • As a Pharmaceutical Industry-Vice President at Berlex-Schering AG (Berlin, Germany), he was responsible for the company's international cancer program in the US, Europe and Asia. (Industry)
  • Dr. Scanlon received his Ph.D. degree from the University of London in Molecular Biology and trained in Cancer Research at Yale Medical School. He was a Leukemia Society Scholar, awarded the Paul Martini Medical Research Prize in Cancer (Germany), was the past President of the International Society of Cell and Cancer Gene Therapy (England), was a participant at 400th Anniversary of Uppsala University (Sweden), is an advisor for the National Institute for Cellular Biotechnology (Ireland), Co-Founder of the Nature Journal, "Cancer Gene Therapy", co-authored over 137 original scientific articles, edited nine medical books and has seven issued patents. (Science)
BiographyEventsArticlesAngel InvestingBoardsConsultingIndustry
TeachingScienceBiotech CenterPhotosWebcastsLinksContact Us

You are visitor number 251,929 to the KJScanlon website.

Baywalk MarketingTop of Page